KUALA LUMPUR, Merz Aesthetics, a medical aesthetics business, has launched Ultherapy PRIME, a non-invasive, FDA-cleared medical aesthetics treatment that provides a truly personalised and long-lasting lift of the skin in one session with zero downtime. Merz Aesthetics Chief Executive Officer, Bob Rhatigan said the launch of Ultherapy PRIME demonstrated the company's commitment to persist in innovation. 'As the leader in non-invasive lifting, we are excited to bring Ultherapy PRIME to our customers as the next generation, premier platform and as a proven technology and customisable, long-lasting treatment option,' he said in a statement. The Ultherapy PRIME platform is the evolution of Ultherapy, which has been recognised as the Gold Standard for nonsurgical lifting due to its large body of clinical evidence, well-established mechanism of action (MOA) and high patient satisfaction. Built on a legacy of proven, natural-looking outcomes, Ultherapy PRIME redefines the future of nonsurgical skin lifting by un iquely combining advanced ultrasound technology, vivid real-time imaging and proven results, thus promoting long-lasting results paired with healthier-looking skin. In addition, the platform's modern design and advanced operating system deliver 20 per cent faster treatments, elevated ergonomics, and more efficient workflows for aesthetic health care professionals. Furthermore, Ultherapy PRIME's 35 per cent larger screen and faster image refresh rate provide brighter, crisper images from all angles, ensuring a vivid visualisation experience. Its unique technology with real-time visualisation goes beyond other non-invasive treatments to target the right collagen and elastin-rich layers of the tissue at multiple depths, delivering consistent and precise energy where the patient needs it the most. With three million Ultherapy treatments performed globally, Ultherapy PRIME effectively and safely lifts the skin on the brows, chin and neck and improves lines and wrinkles on the décolleté. Source: BERNAMA News Agency